Bay City Capital — 2015 Investments
2 investments dated 2015 · listed companies and verified rows first · show all
BiotechSacramento, US
Woodrow A. Myers, Jr.(Director)Vic Schmitt(Director)Chuck Novak(Vice President and Chief Financial Officer of the Issuer)George Barry(Co-Founder of Issuer)Philip H. Coelho(Chief Technology Officer and Co-Founder of Issuer)William Gerber(Chief Executive Officer and President of Issuer)
Board seatCarl Goldfischer· per SEC Form D
Gilead Sciences is a biopharmaceutical company that develops medicines across virology, oncology, and inflammation, with more than 25 medicines offered globally and a clinical pipeline spanning these three therapeutic areas.
BiotechHealthtechNewark, US
Harold Van Wart, Ph. D.(Executive Officer, Director)Carl Goldfischer, M.D.(Director)Pol Boudes(Executive Officer)Kurt von Emster(Director)Hari Kumar, Ph.D.(Director)Charles A. McWherter, Ph. D.(Executive Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.